GERMANY UP CLOSE: BfArM Prepares For A Wave Of App Activity
This article was originally published in Clinica
The regulation of medical apps is still very much a gray area, but Germany’s Federal Institute for Drugs and Medical Devices (BfArM) is seeking to take the initiative and help companies and users understand the new field of play and its rules, as the institute’s head of medical devices Dr Wolfgang Lauer explained to Clinica during Medica 2015
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.